Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke

Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke

Smoking is a leading cause of morbidity and premature mortality among people living with HIV (PLHIV), who have high rates of tobacco smoking. Vaporised nicotine products (VNPs) are growing in popularity as a quit aid and harm reduction tool. However, little is known about their acceptability and use...

Full description

Bibliographic Details
Main Authors: Stephanie Bell, Judith Dean, Charles Gilks, Mark A. Boyd, Lisa Fitzgerald, Allyson Mutch, Peter Baker, Graham Neilsen, Coral E. Gartner
Format: Article
Language:English
Published: MDPI AG 2017-07-01
Series:International Journal of Environmental Research and Public Health
Subjects:
smoking
tobacco
HIV
harm reduction
vaporised nicotine
VNPs
e-cigarettes
feasibility
Online Access:https://www.mdpi.com/1660-4601/14/7/799

Internet

https://www.mdpi.com/1660-4601/14/7/799

Similar Items